Verition Fund Management
MED icon

Verition Fund Management’s Medifast MED Stock Holding History

Verition Fund Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,842
Closed -$265K – 3070
2025
Q4 		$265K Buy
24,842
+3,306
+15% +$39.6K ﹤0.01% 3067
2025
Q3 		$294K Buy
+21,536
New +$301K ﹤0.01% 3303
2024
Q3 		– Sell
-38,773
Closed -$846K – 3406
2024
Q2 		$846K Buy
+38,773
New +$1.03M 0.01% 1777
2022
Q3 		– Sell
-1,264
Closed -$228K – 3170
2022
Q2 		$228K Buy
+1,264
New +$226K ﹤0.01% 1871
2020
Q1 		– Sell
-15,504
Closed -$1.7M – 885
2019
Q4 		$1.7M Buy
+15,504
New +$1.5M 0.05% 302
2019
Q2 		– Sell
-2,400
Closed -$306K – 1257
2019
Q1 		$306K Buy
+2,400
New +$304K 0.02% 827
2018
Q4 		– Sell
-5,363
Closed -$1.19M – 1093
2018
Q3 		$1.19M Buy
5,363
+3,317
+162% +$672K 0.06% 499
2018
Q2 		$328K Buy
+2,046
New +$262K 0.02% 824

Other funds holding MED

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $48.2B AUM 24.23% 1-Year Est. Return